Dare Bioscience, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Dare Bioscience, Inc. (DARE) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $9.92 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-03-28
- Dare Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $9.92M.
- Dare Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$1.50M, a 719.83% decline year-over-year.
- Dare Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $1.50M.
- Dare Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $9.92M.
- Dare Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$484.00K.
- Dare Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$185.00K.
- Dare Bioscience, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$7.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 7 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 100 month |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $9.92M derived: sum of 2 quarters · filed 2018-03-28 | $8.42M derived: sum of 3 quarters · filed 2018-03-28 | $9.92M 10-K · filed 2018-03-28 | ||||
| 2017-09-30 | $9.92M derived: 10-Q 9 month − 8-K/A 6 month · filed 2017-11-13 | $8.42M derived: sum of 2 quarters · filed 2017-11-13 | $9.92M 10-Q · filed 2017-11-13 | $10.30M derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2017-06-30 | -$1.50M derived: 8-K/A 6 month − 10-Q 3 month · filed 2017-10-02 | $0.00 8-K/A · filed 2017-10-02 | $2.12M 10-Q · filed 2017-08-14 | $382.00K derived: sum of 3 quarters · filed 2017-10-02 | $0.00 derived: sum of 4 quarters · filed 2017-10-02 | |||
| 2017-03-31 | $1.50M 10-Q · filed 2017-05-12 | $1.88M derived: sum of 2 quarters · filed 2017-10-02 | $1.50M derived: sum of 3 quarters · filed 2017-10-02 | $1.74M derived: sum of 4 quarters · filed 2017-10-02 | ||||
| 2016-12-31 | $382.00K derived: 8-K/A 12 month − 10-Q 9 month · filed 2017-10-02 | $0.00 derived: sum of 2 quarters · filed 2017-10-02 | $242.00K derived: sum of 3 quarters · filed 2017-10-02 | $0.00 8-K/A · filed 2017-10-02 | -$418.00K 10-K · filed 2017-03-31 | |||
| 2016-09-30 | -$382.00K derived: 10-Q 9 month − 8-K/A 6 month · filed 2016-11-03 | -$140.00K derived: sum of 2 quarters · filed 2017-10-02 | -$382.00K 10-Q · filed 2016-11-03 | -$495.00K derived: sum of 4 quarters · filed 2017-10-02 | ||||
| 2016-06-30 | $242.00K derived: 8-K/A 6 month − 10-Q 3 month · filed 2017-10-02 | $0.00 8-K/A · filed 2017-10-02 | -$355.00K 10-Q · filed 2016-08-04 | -$113.00K derived: sum of 3 quarters · filed 2017-10-02 | -$147.00K derived: sum of 4 quarters · filed 2017-10-02 | |||
| 2016-03-31 | -$242.00K 10-Q · filed 2017-05-12 | -$355.00K derived: sum of 2 quarters · filed 2017-06-13 | -$389.00K derived: sum of 3 quarters · filed 2017-06-13 | -$697.00K derived: sum of 4 quarters · filed 2017-06-13 | ||||
| 2015-12-31 | -$113.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | -$147.00K derived: sum of 2 quarters · filed 2017-06-13 | $0.00 8-K/A · filed 2017-10-02 | -$455.00K derived: sum of 3 quarters · filed 2017-06-13 | -$484.00K 10-K/A · filed 2017-06-13 | |||
| 2015-09-30 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$342.00K derived: sum of 2 quarters · filed 2016-11-03 | -$371.00K 10-Q · filed 2016-11-03 | -$480.00K derived: sum of 4 quarters · filed 2017-06-13 | ||||
| 2015-06-30 | -$308.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$337.00K 10-Q · filed 2016-08-04 | -$446.00K derived: sum of 3 quarters · filed 2017-06-13 | -$524.00K derived: sum of 4 quarters · filed 2017-06-13 | ||||
| 2015-03-31 | -$29.00K 10-Q · filed 2016-05-02 | -$138.00K derived: sum of 2 quarters · filed 2017-06-13 | -$216.00K derived: sum of 3 quarters · filed 2017-06-13 | -$210.00K derived: sum of 4 quarters · filed 2017-06-13 | ||||
| 2014-12-31 | -$109.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-06-13 | -$187.00K derived: sum of 2 quarters · filed 2017-06-13 | -$181.00K derived: sum of 3 quarters · filed 2017-06-13 | -$185.00K 10-K/A · filed 2017-06-13 | ||||
| 2014-09-30 | -$78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$72.00K derived: sum of 2 quarters · filed 2015-11-16 | -$76.00K 10-Q · filed 2015-11-16 | -$76.00K derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $2.00K 10-Q · filed 2015-08-06 | $2.00K derived: sum of 3 quarters · filed 2016-03-10 | $0.00 derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | -$4.00K 10-Q · filed 2015-05-06 | -$4.00K derived: sum of 2 quarters · filed 2016-03-10 | -$6.00K derived: sum of 3 quarters · filed 2016-03-10 | -$9.00K derived: sum of 4 quarters · filed 2016-03-10 | -$2.34M 10-Q · filed 2014-05-27 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$2.00K derived: sum of 2 quarters · filed 2016-03-10 | -$5.00K derived: sum of 3 quarters · filed 2016-03-10 | -$7.00K 10-K · filed 2016-03-10 | ||||
| 2013-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$5.00K derived: sum of 2 quarters · filed 2014-11-13 | -$7.00K 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$5.00K 10-Q · filed 2014-08-12 | ||||||
| 2013-03-31 | -$2.00K 10-Q · filed 2014-05-27 | |||||||
| 2012-12-31 | -$180.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |